Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 7/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 7/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | NSD2 | O96028 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | S100A4 | P26447 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.50 |
| ▸ | RAF1 | P04049 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2481237 | 0.77 | ADORA2A (1.00) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL2483117 | 0.77 | CYP1A2 (0.71) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL30442565 | 0.75 | MAPT (0.60) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL30678387 | 0.75 | MAPT (0.60) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL12311435 | 0.75 | MAPT (0.60) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL13295898 | 0.74 | CYP1A2 (0.67) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL2464584 | 0.72 | L3MBTL1 (0.74) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL12311502 | 0.72 | NR4A1 (0.79) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL3273424 | 0.70 | MAPT (0.97) | MAPTMAPK1KMT2AL3MBTL1MEN1 | |
| SCHEMBL12311433 | 0.69 | CYP1A2 (0.59) | MAPTMAPK1KMT2AL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796676-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-09-01 | — | — | US | disclosed |
| US-9357781-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2014-11-06 | — | — | US | disclosed |
| WO-2014179785-A1 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | INSCENT, INC. (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20070225310-A1 | Antiviral methods and compositions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | MAPT 1877/4885MAPK1 3847/4885KMT2A 794/4885 |
| US-20070225310-A1 | Antiviral methods and compositions | EIF2AK2, ZC3HAV1, MAVS | MAPT 2836/4885MAPK1 4213/4885KMT2A 3900/4885 |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | MAPT 1877/4885MAPK1 3847/4885KMT2A 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.